Stage-specific conditional survival in renal cell carcinoma after nephrectomy

Area of Science:

• Oncology
• Cancer Research
• Nephrology

Background:

• Conditional survival (CS) offers a more refined survival probability by accounting for patient survivorship.
• Stage-specific CS in renal cell carcinoma (RCC) following nephrectomy remains underexplored.
• Standard survival estimates do not incorporate the benefit of time already survived.

Purpose of the Study:

• To investigate stage-specific conditional survival (CS) in renal cell carcinoma (RCC) patients after nephrectomy.
• To evaluate the impact of postoperative survivorship on CS estimates in RCC.
• To determine if CS provides a more accurate survival prediction than standard estimates for RCC.

Main Methods:

• Retrospective analysis of a population-based cohort (87,225 RCC patients) and an institutional validation cohort (1,642 RCC patients).
• Utilized data from the Surveillance, Epidemiology, and End Results database (2004-2015).
• Employed Kaplan-Meier method for 5-year cancer-specific CS estimates and multivariable Cox regression to assess mortality risk variations.

Main Results:

• Initial 5-year cancer-specific survival rates at nephrectomy were 97.4% (Stage I), 89.9% (Stage II), 77.9% (Stage III), and 26.7% (Stage IV).
• Significant improvements in 5-year CS were observed in advanced stages (III and IV) with increased postoperative survivorship.
• For Stage IV patients, CS increased from 34.6% at 1 year to 58.6% at 5 years post-nephrectomy.

Conclusions:

• Conditional survival after nephrectomy for RCC is highly dependent on the initial disease stage.
• Patients with advanced-stage RCC experience the most substantial survival probability gains over time.
• Stage-specific CS estimates are valuable tools for optimizing postoperative surveillance strategies in RCC patients.